KR20220025680A - Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria - Google Patents

Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria Download PDF

Info

Publication number
KR20220025680A
KR20220025680A KR1020210110689A KR20210110689A KR20220025680A KR 20220025680 A KR20220025680 A KR 20220025680A KR 1020210110689 A KR1020210110689 A KR 1020210110689A KR 20210110689 A KR20210110689 A KR 20210110689A KR 20220025680 A KR20220025680 A KR 20220025680A
Authority
KR
South Korea
Prior art keywords
bellflower
postbiotics
fermented
lactic acid
acid bacteria
Prior art date
Application number
KR1020210110689A
Other languages
Korean (ko)
Inventor
신홍식
Original Assignee
(주)케비젠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)케비젠 filed Critical (주)케비젠
Publication of KR20220025680A publication Critical patent/KR20220025680A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/10Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • A23V2250/2116Flavonoids, isoflavones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • A23V2250/2132Other phenolic compounds, polyphenols
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/70Vitamins
    • A23V2250/708Vitamin C
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/169Plantarum
    • A23Y2220/67

Abstract

The present invention relates to a method for manufacturing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria. By using the manufacturing method according to the present invention, it is possible to provide fermented balloon flower postbiotics with an increased content of total polyphenols, total flavonoids and L-ascorbic acid. In addition, it can be usefully used in the manufacture of health functional food for antioxidant, anti-inflammatory, skin whitening, immune enhancement, anticancer effect, and the like.

Description

유산균을 이용한 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스의 제조방법{Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria}Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria

본 발명은 유산균을 이용한 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스의 제조방법에 관한 것이다.The present invention relates to a method for producing bellflower fermented postbiotics with an increased content of useful ingredients using lactic acid bacteria.

유산균은 인간이 이용할 수 있는 가장 유익한 미생물 중의 한 종류로서, 비병원성균으로 인간의 장내에 서식하면서 정장 및 정균작용을 한다. 또한, 당류를 발효해서 다량의 젖산을 생성하고 낮은 pH 및 혐기적인 조건에서도 잘 생육하며 여러 가지 영양물질을 생산하는 특징을 가지고 있다. 유산균에 의해 채소류가 발효되면 독특한 향과 맛을 내게 되어 관능적 특성이 향상되고, 유기산에 의하여 비타민 C와 여러 생리활성물질이 잘 보존되며, 초기 재료에는 거의 존재하지 않았던 비타민 B12와 비타민 K가 생합성되어 부패균과 병원성균의 성장과 증식을 저해하여 위생적인 식품이 되는 등의 장점을 가지고 있는 것으로 알려져 있다.Lactobacillus is one of the most beneficial microorganisms available to humans, and is a non-pathogenic bacteria that live in the human intestine and perform intestinal and bacteriostatic actions. In addition, it has the characteristics of producing a large amount of lactic acid by fermenting sugars, growing well under low pH and anaerobic conditions, and producing various nutrients. When vegetables are fermented by lactic acid bacteria, their unique flavor and taste are improved, and the sensory properties are improved, and vitamin C and various physiologically active substances are well preserved by organic acids. It is known to have the advantage of becoming a hygienic food by inhibiting the growth and proliferation of putrefactive and pathogenic bacteria.

도라지(Platycodon grandiflorum)는 한국, 일본 및 중국의 산간지방에서 널리 자생하며, 한방에서 약재로 사용되기도 하고 일반 식용으로도 널리 이용되고 있는 산채 식품으로서, 트리테르페노이드(triterpenoid)계 사포닌, 당질 및 섬유질을 함유하고 있다. 사포닌은 동물실험에서 진해거담, 중추신경 억제, 항궤양, 위액 분비 억제, 혈압강하, 콜레스테롤 대사 개선, 항산화 및 항암 효과 등이 있는 것으로 밝혀져 있다. 또한, 생약재로서 도라지가 배합되어 있는 한방 처방 수는 동의보감에 287건, 방약합편에 49건이 수록되어 있을 정도로 다양한 약리작용을 가지고 있다. Bellflower ( Platycodon grandiflorum ) is widely grown in mountainous regions of Korea, Japan, and China, and is a wild vegetable food that is widely used as a medicine in oriental medicine and also for general food. Contains fiber. Saponin has been found to have antitussive expectorant, central nervous system suppression, anti-ulcer, gastric juice secretion suppression, blood pressure lowering, cholesterol metabolism improvement, antioxidant and anticancer effects in animal experiments. In addition, the number of oriental medicine prescriptions containing bellflower as a herbal medicine contains 287 cases in Donguibogam and 49 cases in Bangyakhappyeon.

한편, 한국등록특허 제1290795호에는 '유효성분이 증가된 발효 도라지 제조방법'에 대해 개시하고 있으며, 한국등록특허 제1732036에는 '조사포닌 함량이 증가된 도라지추출발효 농축액 및 그 제조방법'에 대해 개시하고 있다. 하지만, 본 발명의 '유산균을 이용한 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스의 제조방법'에 대해서는 아직까지 개시된 바가 없다.On the other hand, Korean Patent No. 1290795 discloses 'a method for producing fermented bellflower with increased active ingredient', and Korean Patent No. 1732036 discloses 'a fermented bellflower extract with increased saponin content and a method for manufacturing the same'. are doing However, the 'method for producing fermented bellflower postbiotics with an increased content of useful ingredients using lactic acid bacteria' of the present invention has not yet been disclosed.

본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 도라지 물에 셀룰라아제(cellulase) 및 폴리갈락투로나아제(polygalacturonase)를 처리한 후 락토바실러스 플랜타룸 CBG-C21(Lactobacillus plantarum CBG-C21) 균주로 발효하고 동결건조하여 도라지 발효 포스트바이오틱스 분말을 제조하였고, 효소 처리 및 발효하지 않은 도라지 분말에 비해 상기 도라지 발효 포스트바이오틱스 분말의 총 폴리페놀(polyphenol), 총 플라보노이드(flavonoid) 및 L-아스코르브산(L-ascorbic acid) 함량이 현저하게 증가하는 것을 확인함으로써, 본 발명을 완성하였다.The present invention was derived from the above needs, and the present inventors treated bellflower water with cellulase and polygalacturonase, and then Lactobacillus plantarum CBG-C21 ( Lactobacillus plantarum CBG-C21) ) strain and freeze-drying to prepare a bellflower fermented postbiotic powder, and compared to a bellflower powder that was not subjected to enzyme treatment and fermentation, the total polyphenols, total flavonoids, and L of the bellflower fermented postbiotic powder - By confirming that the content of ascorbic acid significantly increased, the present invention was completed.

상기 과제를 해결하기 위하여, 본 발명은 1) 도라지에 효소를 처리하는 단계; 및 2) 상기 단계 1)에서 효소 처리한 도라지에 유산균을 접종하여 발효하는 단계;를 포함하는 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스의 제조방법을 제공한다.In order to solve the above problems, the present invention comprises the steps of: 1) treating a bellflower with an enzyme; and 2) inoculating and fermenting the lactic acid bacteria in the bellflower treated with the enzyme in step 1).

또한, 본 발명은 상기 제조방법으로 제조된 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스를 제공한다.In addition, the present invention provides a bellflower fermented postbiotics with an increased content of useful ingredients prepared by the above manufacturing method.

또한, 본 발명은 상기 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스를 포함하는 건강기능식품을 제공한다.In addition, the present invention provides a health functional food comprising the bellflower fermented postbiotics having an increased content of useful ingredients.

본 발명에 따른 제조방법을 이용하면 총 폴리페놀, 총 플라보노이드 및 L-아스코르브산 함량이 증가된 도라지 발효 포스트바이오틱스를 제공할 수 있고, 항산화, 항염증, 피부 미백, 면역 증진, 항암 효과 등을 위한 건강기능식품 제조에 유용하게 이용할 수 있다.By using the manufacturing method according to the present invention, it is possible to provide fermented bellflower postbiotics with an increased content of total polyphenols, total flavonoids and L-ascorbic acid, and exhibit antioxidant, anti-inflammatory, skin whitening, immune enhancement, anticancer effects, etc. It can be usefully used in the manufacture of health functional food for

도 1은 본 발명의 도라지 발효 포스트바이오틱스 내의 총 폴리페놀 함량을 나타낸 것이다.
도 2는 본 발명의 도라지 발효 포스트바이오틱스 내의 총 플라보노이드 함량을 나타낸 것이다.
도 3은 본 발명의 도라지 발효 포스트바이오틱스 내의 L-아스코르브산 함량을 나타낸 것이다.
1 shows the total polyphenol content in bellflower fermented postbiotics of the present invention.
Figure 2 shows the total flavonoid content in the bellflower fermented postbiotics of the present invention.
3 shows the content of L-ascorbic acid in the fermented bellflower postbiotics of the present invention.

본 발명의 목적을 달성하기 위하여, 본 발명은 In order to achieve the object of the present invention, the present invention

1) 도라지에 효소를 처리하는 단계; 및1) treating the bellflower with an enzyme; and

2) 상기 단계 1)에서 효소 처리한 도라지에 유산균을 접종하여 발효하는 단계;를 포함하는 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스(postbiotics)의 제조방법을 제공한다.2) Inoculating and fermenting the lactic acid bacteria in the bellflower treated with the enzyme in step 1); provides a method for producing fermented bellflower postbiotics with an increased content of useful ingredients, including.

본 명세서에서 용어 "포스트바이오틱스"는 건강에 유익한 미생물인 프로바이오틱스(probiotics)가 프리바이오틱스(prebiotics)를 영양원으로 이용하여 생성한 대사 또는 발효 산물을 의미한다. 포스트바이오틱스의 대표적인 형태로는 프로바이오틱스를 특정한 방법으로 가공 처리한 사균체 또는 발효물 등이 있다. As used herein, the term “postbiotics” refers to metabolic or fermentation products produced by probiotics, which are microorganisms beneficial to health, using prebiotics as a nutrient source. As a representative form of postbiotics, there are dead cells or fermented products processed by a specific method of probiotics.

본 발명에서 상기 "도라지 발효 포스트바이오틱스"는 "도라지 유산균 발효물"을 의미한다.In the present invention, the "bellflower fermented postbiotics" means "fermented bellflower lactic acid bacteria".

본 발명의 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스의 제조방법에서, 상기 도라지는 도라지 추출물, 즙 또는 분말과 같은 다양한 형태일 수 있으며, 바람직하게는 도라지 분말에 물을 혼합하여 제조한 도라지물일 수 있으나, 이에 제한되지 않는다.In the method for producing bellflower fermented postbiotics having an increased content of useful ingredients of the present invention, the bellflower may be in various forms such as bellflower extract, juice, or powder, and preferably bellflower water produced by mixing bellflower powder with water. can, but is not limited thereto.

또한, 상기 효소는 셀룰라아제(cellulase) 및 폴리갈락투로나아제(polygalacturonase)일 수 있으나, 이에 제한되지 않는다. 상기 효소는 동시에 또는 순차적으로 처리될 수 있으나, 이에 제한되지 않는다.In addition, the enzyme may be cellulase (cellulase) and polygalacturonase (polygalacturonase), but is not limited thereto. The enzyme may be treated simultaneously or sequentially, but is not limited thereto.

또한, 상기 유산균은 락토바실러스 플랜타룸(Lactobacillus plantarum) 균주일 수 있으며, 바람직하게는 기탁번호가 KACC92083P인 락토바실러스 플랜타룸 CBG-C21(Lactobacillus plantarum CBG-C21) 균주일 수 있으나, 이에 제한되지 않는다.In addition, the lactic acid bacteria may be a Lactobacillus plantarum strain, preferably a Lactobacillus plantarum CBG-C21 strain having an accession number of KACC92083P, but is not limited thereto.

또한, 상기 발효는 32~42℃에서 18~28시간 동안 수행할 수 있으며, 바람직하게는 37℃에서 23시간 동안 수행한 것일 수 있으나, 이에 제한되지 않는다.In addition, the fermentation may be performed at 32-42° C. for 18-28 hours, preferably at 37° C. for 23 hours, but is not limited thereto.

또한, 상기 도라지 발효 포스트바이오틱스 내의 함량이 증가된 유용성분은 총 폴리페놀(polyphenol), 총 플라보노이드(flavonoid) 및 L-아스코르브산(L-ascorbic acid)일 수 있으나, 이에 제한되지 않는다.In addition, the useful ingredients with an increased content in the bellflower fermented postbiotics may be total polyphenols, total flavonoids, and L-ascorbic acid, but is not limited thereto.

본 발명에 따른 상기 제조방법은 바람직하게는,The manufacturing method according to the present invention is preferably,

1) 25~35%(w/v) 도라지물에 셀룰라아제(cellulase) 및 폴리갈락투로나아제(polygalacturonase)를 처리하고 50~60℃에서 1.5~2.5시간 동안 반응시키는 단계; 및 1) 25-35% (w/v) of bellflower water is treated with cellulase and polygalacturonase and reacted at 50-60° C. for 1.5-2.5 hours; and

2) 상기 단계 1)에서 셀룰라아제 및 폴리갈락투로나아제를 처리한 도라지물에 3.0×107~3.0×109 CFU/㎖의 락토바실러스 플랜타룸 CBG-C21 균주를 접종하여 32~42℃에서 18~28시간 동안 발효하는 단계;를 포함할 수 있으며, 가장 바람직하게는,2) Inoculate the Lactobacillus plantarum CBG-C21 strain at 3.0×10 7 to 3.0×10 9 CFU/ml into the bellflower water treated with cellulase and polygalacturonase in step 1) at 32 to 42°C. Fermentation for 18 to 28 hours; may include, and most preferably,

1) 30%(w/v) 도라지물에 0.1%(w/v) 셀룰라아제 및 0.1%(w/v) 폴리갈락투로나아제를 처리하고 55℃에서 2시간 동안 반응시키는 단계; 및 1) 30% (w/v) bellflower water was treated with 0.1% (w/v) cellulase and 0.1% (w/v) polygalacturonase and reacted at 55° C. for 2 hours; and

2) 상기 단계 1)에서 셀룰라아제 및 폴리갈락투로나아제를 처리한 도라지물에 3.0×108 CFU/㎖의 락토바실러스 플랜타룸 CBG-C21 균주를 접종하여 37℃에서 23시간 동안 발효하는 단계;를 포함할 수 있으나, 이에 제한되지 않는다.2) inoculating the Lactobacillus plantarum CBG-C21 strain of 3.0×10 8 CFU/ml into the bellflower water treated with cellulase and polygalacturonase in step 1) and fermenting at 37° C. for 23 hours; may include, but is not limited thereto.

또한, 본 발명에 따른 제조방법은 상기 단계 2)의 발효물을 동결건조하는 단계를 추가로 포함할 수 있으나, 이에 제한되지 않는다.In addition, the manufacturing method according to the present invention may further include the step of freeze-drying the fermented product of step 2), but is not limited thereto.

본 발명은 또한, 상기 제조방법으로 제조된 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스를 제공한다. 상기 유용성분은 전술한 바와 같다.The present invention also provides a bellflower fermented postbiotics with an increased content of useful ingredients prepared by the above manufacturing method. The useful ingredients are the same as described above.

상기 포스트바이오틱스는 분말, 과립, 환, 정제, 캡슐, 캔디, 시럽, 발포정 및 음료 중에서 선택된 어느 하나의 제형으로 제조될 수 있으나, 이에 제한되지 않는다.The postbiotics may be prepared in any one formulation selected from powder, granule, pill, tablet, capsule, candy, syrup, effervescent tablet and beverage, but is not limited thereto.

본 발명은 또한, 상기 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스를 포함하는 건강기능식품을 제공한다. 상기 유용성분은 전술한 바와 같다.The present invention also provides a health functional food comprising the bellflower fermented postbiotics having an increased content of useful ingredients. The useful ingredients are the same as described above.

상기 건강기능식품의 종류에는 특별한 제한은 없다. 상기 도라지 발효 포스트바이오틱스를 함유하는 건강기능식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 떡류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강기능식품을 모두 포함한다.There is no particular limitation on the type of the health functional food. Examples of health functional foods containing the bellflower fermented postbiotics include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, rice cakes, dairy products including ice cream, various soups, There are beverages, teas, drinks, alcoholic beverages, and vitamin complexes, and includes all health functional foods in the ordinary sense.

본 발명에 따른 도라지 발효 포스트바이오틱스는 효소 처리 및 발효하지 않은 도라지에 비해 총 폴리페놀, 총 플라보노이드 및 L-아스코르브산의 함량이 증가된 것으로, 상기 유용성분들의 항산화, 항염증, 피부 미백, 면역 증진, 항암 기능 등을 이용하여 다양한 건강기능식품을 제조할 수 있다.In the bellflower fermented postbiotics according to the present invention, the content of total polyphenols, total flavonoids and L-ascorbic acid is increased compared to bellflower without enzyme treatment and fermentation, and the antioxidant, anti-inflammatory, skin whitening, and immunity of the useful ingredients It is possible to manufacture various health functional foods by using enhancement and anti-cancer functions.

상기 건강기능식품은 분말, 과립, 환, 정제, 캡슐, 캔디, 시럽, 발포정 및 음료 중에서 선택된 어느 하나의 제형으로 제조될 수 있으나, 이에 제한되지 않는다.The health functional food may be prepared in any one formulation selected from powder, granule, pill, tablet, capsule, candy, syrup, effervescent tablet and beverage, but is not limited thereto.

본 발명의 도라지 발효 포스트바이오틱스를 식품첨가물로 사용하는 경우, 상기 도라지 발효 포스트바이오틱스를 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분은 그의 사용 목적에 따라 적절하게 사용될 수 있다. 일반적으로, 식품 또는 음료의 제조시에 본 발명의 도라지 발효 포스트바이오틱스는 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양의로 첨가된다. 그러나 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 안전성 면에서 아무런 문제가 없는 범위의 양으로 사용될 수 있다.When using the bellflower fermented postbiotics of the present invention as a food additive, the bellflower fermented postbiotics may be added as it is or used together with other foods or food ingredients, and may be appropriately used according to a conventional method. The active ingredient may be appropriately used depending on the purpose of its use. In general, in the production of food or beverage, the bellflower fermented postbiotics of the present invention are added in an amount of 15 parts by weight or less, preferably 10 parts by weight or less, based on the raw material. However, in the case of long-term intake for the purpose of health control, it can be used in an amount within a range that does not cause any problems in terms of safety.

본 발명의 건강기능식품은 식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함시킬 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등), 디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등) 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다. 상기 건강기능식품 조성물 외에 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. The health functional food of the present invention includes ingredients commonly added during food production, for example, proteins, carbohydrates, fats, nutrients and seasonings. For example, when manufactured as a drink, natural carbohydrates or flavoring agents may be included as additional ingredients in addition to the active ingredient. The natural carbohydrates include monosaccharides (eg, glucose, fructose, etc.), disaccharides (eg, maltose, sucrose, etc.), oligosaccharides, polysaccharides (eg, dextrin, cyclodextrin, etc.) or sugar alcohols (eg, , xylitol, sorbitol, erythritol, etc.) is preferable. As the flavoring agent, natural flavoring agents (eg, taumartin, stevia extract, etc.) and synthetic flavoring agents (eg, saccharin, aspartame, etc.) may be used. In addition to the above health functional food composition, various nutrients, vitamins, electrolytes, flavoring agents, colorants, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, carbonic acid It may further contain a carbonation agent and the like used in beverages.

상기 첨가되는 성분의 비율은 크게 중요하진 않지만 본 발명의 건강기능식품 100 중량부에 대하여, 0.01 내지 0.1 중량부의 범위에서 선택되는 것이 일반적이다.Although the proportion of the added component is not very important, it is generally selected in the range of 0.01 to 0.1 parts by weight based on 100 parts by weight of the health functional food of the present invention.

이하, 본 발명의 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, an embodiment of the present invention will be described in detail. However, the following examples only illustrate the present invention, and the content of the present invention is not limited to the following examples.

제조예 1. 도라지 발효 포스트바이오틱스 제조Preparation Example 1. Preparation of bellflower fermented postbiotics

90.97 g의 도라지 분말을 칭량하여 210 ㎖의 정제수와 혼합하여 30%(w/v)의 도라지물을 제조하였다. 이후, pH 7.0으로 보정하고 덱스트린을 첨가한 후, 동결건조하고 분말화하여 대조군(도라지 분말)으로 이용하였다. 90.97 g of bellflower powder was weighed and mixed with 210 ml of purified water to prepare 30% (w/v) bellflower water. Thereafter, the pH was corrected to 7.0 and dextrin was added, lyophilized and powdered, and used as a control (bellflower powder).

도라지의 발효를 위하여 락토바실러스 플랜타룸(Lactobacillus plantarum) CBG-C21 균주(기탁번호: KACC92083P)를 24시간 동안 배양하여 6.0×109 CFU/㎖의 균주 배양액을 준비하였다. 상기 도라지물에 0.1%(w/v)의 셀룰라아제(cellulase) 및 0.1%(w/v)의 폴리갈락투로나아제(polygalacturonase)를 처리하여 55℃에서 2시간 동안 반응시킨 후, 2%(w/v) 포도당 및 1%(w/v) 카제인 펩톤을 첨가하여 121℃에서 15분간 가압멸균하였다. 이후, 효소 처리한 도라지물에 상기 락토바실러스 플랜타룸 CBG-C21 균주 배양액 5%(3.0×108 CFU/㎖)를 접종하여 37℃에서 23시간 동안 정치배양하여 발효를 수행하였다. 발효가 완료된 도라지 발효액에 덱스트린을 첨가한 후, 동결건조하고 분말화하여 도라지 발효 포스트바이오틱스 분말을 제조하였다.For the fermentation of bellflower, Lactobacillus plantarum CBG-C21 strain (Accession No.: KACC92083P) was cultured for 24 hours to prepare a strain culture solution of 6.0×10 9 CFU/ml. The bellflower water was treated with 0.1% (w/v) cellulase and 0.1% (w/v) polygalacturonase and reacted at 55° C. for 2 hours, followed by 2% ( w/v) glucose and 1% (w/v) casein peptone were added and autoclaved at 121° C. for 15 minutes. Thereafter, the enzyme-treated bellflower water was inoculated with 5% (3.0×10 8 CFU/ml) of the Lactobacillus plantarum CBG-C21 strain culture, and fermented by stationary culture at 37° C. for 23 hours. After dextrin was added to the fermented bellflower fermented broth, lyophilized and powdered to prepare a fermented bellflower postbiotic powder.

실시예 1. 유용성분 함량 분석Example 1. Analysis of the content of useful ingredients

상기 제조예 1의 도라지 분말 및 도라지 발효 포스트바이오틱스 분말을 대상으로 항산화 관련 유용성분인 총 폴리페놀(polyphenol), 총 플라보노이드(flavonoid) 및 L-아스코르브산(L-ascorbic acid) 함량을 측정하였다. 총 폴리페놀 함량 측정은 싱글톤 및 로시의 방법(Singleton, V. and Rossi, J et al., 1965, American Journal of Enology and Viticulture. 16:144-158)을 일부 변형하여 측정하였다. 시료 용액 및 갈산(gallic acid) 표준물질(20, 40, 60, 80, 100 mg/L) 1 ㎖을 9 ㎖의 3차 증류수가 들어 있는 25 ㎖ 정량 플라스크에 각각 넣고, 페놀용액(Folin-ciocalteu's phenol reagent) 1 ㎖을 첨가하였다. 5분 후 7% Na2CO3 용액 10 ㎖을 가하여 충분히 교반한 다음 3차 증류수로 25 ㎖을 채워서 혼합하여 23℃에서 90분간 반응시킨 후 750 nm에서 blank를 대조군으로 하여 흡광도를 측정하였다. 이때, 표준 검량 곡선은 표준 물질로서 갈산을 일정 농도로 하여 상기와 동일한 방법으로 측정하여 획득하였으며, 시료의 흡광도를 표준 검량 곡선에 대입하여 총 페놀 함량을 ㎍/g로 나타내었다Total polyphenols, total flavonoids, and L-ascorbic acid, which are useful antioxidant-related ingredients, were measured for the bellflower powder and bellflower fermented postbiotic powder of Preparation Example 1. The total polyphenol content was measured with some modifications of the Singleton and Rossi method (Singleton, V. and Rossi, J et al., 1965, American Journal of Enology and Viticulture. 16:144-158). Put 1 ml of the sample solution and gallic acid standard (20, 40, 60, 80, 100 mg/L) into a 25 ml quantitative flask containing 9 ml of tertiary distilled water, respectively, and phenol solution (Folin-ciocalteu's) phenol reagent) 1 ㎖ was added. After 5 minutes, 10 ml of a 7% Na 2 CO 3 solution was added and sufficiently stirred. Then, 25 ml of tertiary distilled water was filled, mixed, and reacted at 23° C. for 90 minutes. Absorbance was measured at 750 nm using a blank as a control. At this time, the standard calibration curve was obtained by measuring in the same manner as above using gallic acid as a standard material at a constant concentration, and the absorbance of the sample was substituted into the standard calibration curve to express the total phenol content in μg/g.

총 플라보노이드 함량은 지센의 방법(Zhishen J. et al., 1999, Food Chemistry. 64:555-559)을 변형하여 측정하였다. 시료 용액 및 퀘세틴(quercetin) 표준물질(20, 40, 60, 80, 100 mg/L) 1 ㎖을 4 ㎖의 3차 증류수가 들어있는 10 ㎖ 정량 플라스크에 각각 넣고 제로 타임에 5% NaNO2를 0.3 ㎖ 첨가하여 충분히 교반하였다. 5분 후 10% AlCl3을 0.3 ㎖ 넣어주고 6분이 되었을 때 1M NaOH를 2 ㎖ 첨가하고 즉시 3차 증류수를 2.4 ㎖ 첨가하여 완전히 혼합한 후 실온에서 1분간 반응시킨 다음 UV/Vis Spectrometer를 이용하여 510 nm에서 blank를 대조군으로 하여 각 용액의 흡광도를 측정하였다. 이때, 총 플라보노이드 함량은 표준 물질로서 퀘세틴을 일정 농도로 하여 상기와 동일한 방법으로 측정하여 획득하였으며, 시료의 흡광도를 표준 검량 곡선에 대입하여 총 플라보노이드 함량을 ㎍/g로 나타내었다.Total flavonoid content was determined by modifying Zhishen's method (Zhishen J. et al., 1999, Food Chemistry. 64:555-559). Add 1 ml of the sample solution and quercetin standard (20, 40, 60, 80, 100 mg/L) to a 10 ml quantitative flask containing 4 ml of tertiary distilled water, respectively, and at zero time, 5% NaNO 2 0.3 ml was added, and the mixture was sufficiently stirred. After 5 minutes, 0.3 mL of 10% AlCl 3 was added, and at 6 minutes, 2 mL of 1M NaOH was added, and immediately, 2.4 mL of tertiary distilled water was added, mixed thoroughly, and reacted at room temperature for 1 minute, then using UV/Vis Spectrometer The absorbance of each solution was measured at 510 nm using the blank as a control. At this time, the total flavonoid content was obtained by measuring in the same way as above using a certain concentration of querycetin as a standard material, and substituting the absorbance of the sample into the standard calibration curve to express the total flavonoid content in μg/g.

L-아스코르브산 함량은 Megazyme assay kit(Megazyme Ltd.)를 이용하여 측정하였다. 구체적으로, 100 mg의 시료에 3%(w/v) 메타인산(metaphosphoric acid) 및 10 mM EDTA(ethylenediaminetetraacetic acid)를 첨가하여 상온에서 60분간 균질화하고 10분간 원심분리한 후 수득한 상등액을 여과하여 사용하였다. 10 ㎕의 여과한 상등액에 152 ㎕의 3차 증류수 및 버퍼 1을 혼합하고 3분 후 MTT[3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide] 버퍼 2를 넣고 3분간 반응시켰으며, 분광광도계를 이용하여 578 nm에서 1차 흡광도(A1)를 측정하고, PMS(5-methylphenazinium methyl sulfate) 버퍼를 넣고 8분 동안 반응시킨 후 578 nm에서 2차 흡광도(A2)를 측정하였다. The L-ascorbic acid content was measured using a Megazyme assay kit (Megazyme Ltd.). Specifically, 3% (w/v) metaphosphoric acid and 10 mM EDTA (ethylenediaminetetraacetic acid) were added to a 100 mg sample, homogenized at room temperature for 60 minutes, centrifuged for 10 minutes, and the obtained supernatant was filtered. was used. 152 μl of tertiary distilled water and buffer 1 were mixed with 10 μl of the filtered supernatant, and after 3 minutes, MTT[3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide] buffer 2 was added and reacted for 3 minutes The primary absorbance (A1) was measured at 578 nm using a spectrophotometer, and a PMS (5-methylphenazinium methyl sulfate) buffer was added and reacted for 8 minutes. Secondary absorbance (A2) was measured at 578 nm. .

그 결과, 하기 표 1에 개시한 바와 같이 효소 처리 및 발효하지 않은 도라지 분말에 비해 도라지 발효 포스트바이오틱스 내의 총 폴리페놀, 총 플라보노이드 및 L-아스코르브산 함량이 유의하게 증가한 것을 확인할 수 있었다(도 1 내지 도 3).As a result, as shown in Table 1 below, it was confirmed that the total polyphenols, total flavonoids and L-ascorbic acid contents in the bellflower fermented postbiotics were significantly increased compared to the bellflower powder without enzyme treatment and fermentation (Fig. 1) to 3).

도라지 발효 포스트바이오틱스 내의 유용성분 함량 측정 결과Measurement result of useful ingredient content in bellflower fermented postbiotics 유용성분useful ingredients 도라지 분말bellflower powder 도라지 발효
포스트바이오틱스 분말
Fermentation of bellflower
Postbiotic Powder
총 폴리페놀(㎍/g)Total polyphenols (μg/g) 466.52±1.79466.52±1.79 519.71±3.80519.71±3.80 총 플라보노이드(㎍/g)Total flavonoids (μg/g) 84.0±0.3184.0±0.31 103.6±0.40103.6±0.40 L-아스코르브산(g/100g)L-Ascorbic Acid (g/100g) 1680±27.261680±27.26 1955±40.371955±40.37

농업생명공학연구원Agricultural Biotechnology Research Institute KACC92083PKACC92083P 2015071020150710

Claims (7)

1) 도라지에 효소를 처리하는 단계; 및
2) 상기 단계 1)에서 효소 처리한 도라지에 유산균을 접종하여 발효하는 단계;를 포함하는 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스(postbiotics)의 제조방법.
1) treating the bellflower with an enzyme; and
2) Inoculating and fermenting the lactic acid bacteria in the bellflower treated with the enzyme in step 1).
제1항에 있어서, 상기 효소는 셀룰라아제(cellulase) 및 폴리갈락투로나아제(polygalacturonase)인 것을 특징으로 하는 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스의 제조방법.The method of claim 1, wherein the enzyme is cellulase and polygalacturonase. 제1항에 있어서, 상기 유산균은 기탁번호가 KACC92083P인 락토바실러스 플랜타룸 CBG-C21(Lactobacillus plantarum CBG-C21) 균주인 것을 특징으로 하는 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스의 제조방법.The method of claim 1, wherein the lactic acid bacteria is a Lactobacillus plantarum CBG-C21 strain having an accession number of KACC92083P. 제1항에 있어서, 상기 유용성분은 총 폴리페놀(polyphenol), 총 플라보노이드(flavonoid) 및 L-아스코르브산(L-ascorbic acid)인 것을 특징으로 하는 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스의 제조방법.The method of claim 1, wherein the useful ingredients are total polyphenols, total flavonoids, and L-ascorbic acid. manufacturing method. 제1항에 있어서,
1) 도라지물에 셀룰라아제(cellulase) 및 폴리갈락투로나아제(polygalacturonase)를 처리하고 50~60℃에서 1.5~2.5시간 동안 반응시키는 단계; 및
2) 상기 단계 1)에서 셀룰라아제 및 폴리갈락투로나아제를 처리한 도라지물에 기탁번호가 KACC92083P인 락토바실러스 플랜타룸 CBG-C21 균주를 접종하여 32~42℃에서 18~28시간 동안 발효하는 단계;를 포함하는, 총 폴리페놀(polyphenol), 총 플라보노이드(flavonoid) 및 L-아스코르브산(L-ascorbic acid)의 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스의 제조방법.
According to claim 1,
1) treating bellflower water with cellulase and polygalacturonase and reacting at 50 to 60° C. for 1.5 to 2.5 hours; and
2) Inoculating the Lactobacillus plantarum CBG-C21 strain with the accession number KACC92083P into the bellflower water treated with cellulase and polygalacturonase in step 1), and fermenting it at 32~42℃ for 18~28 hours A method for producing fermented bellflower postbiotics with an increased content of useful components of total polyphenols, total flavonoids, and L-ascorbic acid, including;
제1항 내지 제5항 중 어느 한 항의 제조방법으로 제조된 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스.[Claim 6] Fermented bellflower postbiotics with an increased content of useful ingredients prepared by the method of any one of claims 1 to 5. 제6항의 유용성분 함량이 증가된 도라지 발효 포스트바이오틱스를 포함하는 건강기능식품.A health functional food containing bellflower fermented postbiotics with an increased content of useful ingredients of claim 6.
KR1020210110689A 2020-08-24 2021-08-23 Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria KR20220025680A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20200106051 2020-08-24
KR1020200106051 2020-08-24

Publications (1)

Publication Number Publication Date
KR20220025680A true KR20220025680A (en) 2022-03-03

Family

ID=80818909

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210110689A KR20220025680A (en) 2020-08-24 2021-08-23 Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria

Country Status (1)

Country Link
KR (1) KR20220025680A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102595524B1 (en) * 2023-08-07 2023-10-30 주식회사 그레잇풀 Platycodon grandiflorum fermented product comprising platycodon grandiflorum and rice grain syrup and method for preparing thereof
KR102652207B1 (en) * 2023-08-25 2024-04-01 주식회사 큰마당 Method for producing a fermented product in which the contents of saponin and compound K are changed by fermentation of bellflower concentrate, and a composition containing the fermented product produced through the method

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102595524B1 (en) * 2023-08-07 2023-10-30 주식회사 그레잇풀 Platycodon grandiflorum fermented product comprising platycodon grandiflorum and rice grain syrup and method for preparing thereof
KR102652207B1 (en) * 2023-08-25 2024-04-01 주식회사 큰마당 Method for producing a fermented product in which the contents of saponin and compound K are changed by fermentation of bellflower concentrate, and a composition containing the fermented product produced through the method

Similar Documents

Publication Publication Date Title
KR20220025679A (en) Method for producing fermented apple postbiotics with increased effective component content using lactic acid bacteria
KR101679388B1 (en) Method for producing fermented velvet antler or hard antler with enhanced ganglioside and sialic acid content and health product for joint and cartilage comprising fermentation product produced by the same method
KR101467837B1 (en) Manufacturing method of fermented red ginseng extract with enhanced ginsenosides Rg3 and antioxidant activity
KR101768921B1 (en) Pediococcus acidilactici SRCM 102024 starter strain for producing fermented grain with improved antimicrobial activity and uses thereof
KR101365917B1 (en) Making method for fermentation beverage of rubus coreanus
KR20220025680A (en) Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria
KR102214532B1 (en) health food composition using pomegranate fermented by lactic acid bacteria and manufacturing method thereof
CN101544941A (en) Waxberry wine and brewing method thereof
KR20160096967A (en) Composition for preventing respiratorydisease, immune-enhancing, anti-obesity containing fermented Platycodon grandiflorum
Chen et al. Traditional food, modern food and nutritional value of Sea buckthorn (Hippophae rhamnoides L.): A review
KR102394733B1 (en) Method for producing fermented spinach and fermented soybean with increased effective component content using lactic acid bacteria
KR20190024420A (en) Manufacturing method of soybean-yogurt improved taste and increased number of viable lactic acid bacteria
KR20220025681A (en) Method for producing fermented cranberry postbiotics with increased effective component content using lactic acid bacteria
KR100773059B1 (en) Novel microorganism having deglycosylating ability, the probiotics containing the same and the process for preparing them
KR101871169B1 (en) New kimchi lactic acid bacteria Weissella cibaria MFST and composition using concentrated extract of Ziziphus jujuba seed
KR20220025678A (en) Method for producing fermented barley sprout postbiotics with increased effective component content using lactic acid bacteria
KR20220136107A (en) Method for producing fermented product by lactic acid bacteria of Aloe with increased effective component content and postbioics products containing the same
KR20200078171A (en) The manufacturing method of fermented red ginseng extracts enhanced with ginsenoside compound K, Rd and Rd3 using β-glucosidase and lactic acid bacteria
KR101494664B1 (en) fermented corni fructus composition with antioxidant activity and method of making the same
KR20230129136A (en) Composition for antibacterial, antioxidant, or anti-inflammatory comprising fermented extracts of Canavalia gladiata leaf as an active ingredient
KR102030902B1 (en) Fermentation method of lactic acid bacteria using fruit of Prunus sp. and its use
KR20200049356A (en) Platycodon grandiflorum Liquid composition for stick-type container having increased ginsenosides of human body absorption type, and preparation method thereof
KR102216618B1 (en) Fermentation method of lactic acid bacteria using artichoke and its use
KR102259131B1 (en) The manufacturing method of fermented red ginseng extracts enhanced with ginsenoside compound K, Rd and Rd3 using β-glucosidase and lactic acid bacteria
KR102224926B1 (en) Lactobacillus sakei NY518 strain, culture thereof and enteric health improving functional food composition comprising the same

Legal Events

Date Code Title Description
E902 Notification of reason for refusal